An evaluation of the double-blind trial as a method of assessing promazine ("Sparine") in the treatment of chronic psychotic patients.
D002908:Chronic Disease; D004311:Double-Blind Method; D001523:Mental Disorders; D011395:Promazine / Q000628:therapy*; D012559:Schizophrenia / Q000628:therapy*
D011395:Promazine
PROMAZINE/therapy; SCHIZOPHRENIA/therapy